EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis

EPA:ERF • FR0014000MR3

65.46 EUR
+1.44 (+2.25%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ERF. ERF was compared to 21 industry peers in the Life Sciences Tools & Services industry. ERF has an average financial health and profitability rating. ERF has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ERF was profitable.
  • In the past year ERF had a positive cash flow from operations.
  • In the past 5 years ERF has always been profitable.
  • In the past 5 years ERF always reported a positive cash flow from operatings.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • With a decent Return On Assets value of 6.29%, ERF is doing good in the industry, outperforming 71.43% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 15.21%, ERF is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • ERF has a better Return On Invested Capital (11.61%) than 76.19% of its industry peers.
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROIC 11.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of ERF (6.48%) is worse than 61.90% of its industry peers.
  • In the last couple of years the Profit Margin of ERF has declined.
  • Looking at the Operating Margin, with a value of 12.42%, ERF is doing worse than 71.43% of the companies in the same industry.
  • ERF's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 22.25%, ERF is doing worse than 85.71% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ERF has declined.
Industry RankSector Rank
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ERF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ERF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 3.00 indicates that ERF is not in any danger for bankruptcy at the moment.
  • ERF has a Altman-Z score of 3.00. This is comparable to the rest of the industry: ERF outperforms 57.14% of its industry peers.
  • ERF has a debt to FCF ratio of 5.14. This is a neutral value as ERF would need 5.14 years to pay back of all of its debts.
  • ERF has a Debt to FCF ratio of 5.14. This is in the better half of the industry: ERF outperforms 61.90% of its industry peers.
  • ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
  • ERF has a Debt to Equity ratio of 0.82. This is comparable to the rest of the industry: ERF outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 3
ROIC/WACC1.24
WACC9.38%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that ERF should not have too much problems paying its short term obligations.
  • ERF's Current ratio of 1.09 is in line compared to the rest of the industry. ERF outperforms 47.62% of its industry peers.
  • ERF has a Quick Ratio of 1.03. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • ERF has a Quick ratio (1.03) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • ERF shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.23% yearly.
  • The Revenue has grown by 53.32% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 6.05% on average over the past years.
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • Based on estimates for the next years, ERF will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.10% on average per year.
  • ERF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.79% yearly.
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.1%
Revenue Next Year5.78%
Revenue Next 2Y6.35%
Revenue Next 3Y7.37%
Revenue Next 5Y7.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.60, the valuation of ERF can be described as rather expensive.
  • Based on the Price/Earnings ratio, ERF is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
  • ERF's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.97.
  • With a Price/Forward Earnings ratio of 16.20, ERF is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ERF indicates a somewhat cheap valuation: ERF is cheaper than 76.19% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ERF to the average of the S&P500 Index (27.96), we can say ERF is valued slightly cheaper.
Industry RankSector Rank
PE 17.6
Fwd PE 16.2
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ERF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ERF is cheaper than 85.71% of the companies in the same industry.
  • 90.48% of the companies in the same industry are more expensive than ERF, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.82
EV/EBITDA 7.83
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ERF's earnings are expected to grow with 15.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y12.5%
EPS Next 3Y15.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.05%, ERF has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.44, ERF pays a better dividend. On top of this ERF pays more dividend than 90.48% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.79, ERF's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.05%

5.2 History

  • The dividend of ERF is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 15.92% of the earnings are spent on dividend by ERF. This is a low number and sustainable payout ratio.
  • ERF's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP15.92%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EUROFINS SCIENTIFIC

EPA:ERF (2/13/2026, 7:00:00 PM)

65.46

+1.44 (+2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)07-21
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.92B
Revenue(TTM)10.66B
Net Income(TTM)691.00M
Analysts68.42
Price Target70.01 (6.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.05%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP15.92%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.51%
PT rev (3m)8.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.47%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.6
Fwd PE 16.2
P/S 1.12
P/FCF 13.82
P/OCF 8.52
P/B 2.62
P/tB N/A
EV/EBITDA 7.83
EPS(TTM)3.72
EY5.68%
EPS(NY)4.04
Fwd EY6.17%
FCF(TTM)4.74
FCFY7.24%
OCF(TTM)7.69
OCFY11.74%
SpS58.51
BVpS24.95
TBVpS-4.41
PEG (NY)1.62
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROCE 15.48%
ROIC 11.61%
ROICexc 12.8%
ROICexgc 41.1%
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
FCFM 8.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 1.9
Cap/Depr 85.24%
Cap/Sales 5.04%
Interest Coverage 11.51
Cash Conversion 71.65%
Profit Quality 124.89%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 3
F-Score6
WACC9.38%
ROIC/WACC1.24
Cap/Depr(3y)81.48%
Cap/Depr(5y)89.24%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.16%
Profit Quality(3y)196.03%
Profit Quality(5y)160.87%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.1%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year5.78%
Revenue Next 2Y6.35%
Revenue Next 3Y7.37%
Revenue Next 5Y7.79%
EBIT growth 1Y27.19%
EBIT growth 3Y-8.55%
EBIT growth 5Y-4.98%
EBIT Next Year83.08%
EBIT Next 3Y29.99%
EBIT Next 5Y25.16%
FCF growth 1Y9.17%
FCF growth 3Y21.94%
FCF growth 5Y-0.12%
OCF growth 1Y6.15%
OCF growth 3Y7.21%
OCF growth 5Y2.73%

EUROFINS SCIENTIFIC / ERF.PA FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.


What is the valuation status for ERF stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for EUROFINS SCIENTIFIC?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 4 / 10.


What is the earnings growth outlook for EUROFINS SCIENTIFIC?

The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 10.84% in the next year.


Can you provide the dividend sustainability for ERF stock?

The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 5 / 10 and the dividend payout ratio is 15.92%.